M2 macrophage immunotherapy abolishes glucose intolerance by increasing IL-10 expression and AKT activation.
Vega-Galaviz D, Vecchyo-Tenorio GD, Alcántara-Suárez R, Méndez-García LA, Sánchez-Del Real AL, Villalobos-Molina R, Fragoso JM, León-Cabrera S, Ostoa-Saloma P, Pérez-Tamayo R, Escobedo G.
Vega-Galaviz D, et al. Among authors: fragoso jm.
Immunotherapy. 2020 Jan;12(1):9-24. doi: 10.2217/imt-2019-0080. Epub 2020 Jan 9.
Immunotherapy. 2020.
PMID: 31914828